CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 187, January 2006
© 2006 American Association for Cancer Research
Please note that an error was made in the publication of a paper in the November 2005 issue (1). The legends for Tables 1 and 2 are correct; however, the actual tables included under each table heading have been reversed. Table 1 refers to the absolute risk values for CIN3+ outcomes. However, it is the table for CIN2+ outcomes that is shown. Similarly, the label for Table 2 accurately states that it will show CIN2+ outcomes but it is the CIN3+ table that is shown.


View this table:
[in this window]
[in a new window]
  		Table 1. Risks (positive predictive values) for single, two-stage, and three-stage strategies for CIN3+ as diagnosed by the ALTS clinical center pathologists among women referred for ASCUS and LSIL cytology

 

View this table:
[in this window]
[in a new window]
  		Table 2. Risks (positive predictive values) for single, two-stage, and three-stage strategies for CIN2+ as diagnosed by the ALTS Pathology QC Group among women referred for ASCUS or LSIL cytology

 

   References
Top
 References
 
  1. Wang SS, et al. Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods. Cancer Epidemiol Biomarkers Prev 2005;14:2665–8.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online